References and Further Reading
Amin, M. B., Edge, S. B., Greene, F. L., et al. (2017). AJCC cancer staging manual (8th ed.). Cham: Springer.
Epstein, J. I., Egevad, L., Humphrey, P. A., Montironi, R., & Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. (2014). Best practices recommendations in the application of immunohistochemistry in the prostate: Report from the International Society of Urologic Pathology consensus conference. The American Journal of Surgical Pathology, 38(8), e6–e19.
Epstein, J. I., Egevad, L., Amin, M. B., et al. (2016). The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: Definition of grading patterns and proposal for a new grading system. The American Journal of Surgical Pathology, 40(2), 244–252.
Gandhi, J., Afridi, A., Vatsia, S., Joshi, G., Joshi, G., Kaplan, S. A., Smith, N. L., & Khan, S. (2018). The molecular biology of prostate cancer: Current understanding and clinical implications. Prostate Cancer and Prostatic Diseases, 21(1), 22–36.
Gleason, D. F. (1966). Classification of prostatic carcinomas. Cancer Chemotherapy Reports, 50(3), 125–128.
Humphrey, P. A. (2003). Prostate pathology. Chicago: American Society for Clinical Pathology Press. ISBN 089189439X, 9780891894391.
Humphrey, P. A. (2018). Variants of acinar adenocarcinoma of the prostate mimicking benign conditions. Modern Pathology, 31(S1), S64–S70.
Moch, H., Humphrey, P. A., & Ulbright, T. M. (Eds.). (2016). WHO classification of tumours of the urinary system and male genital organs (4th ed., pp. 138–161). Lyon: International Agency for Research on Cancer.
Nguyen, J. K., & Magi-Galluzzi, C. (2018). Unfavorable pathology, tissue biomarkers and genomic tests with clinical implications in prostate cancer management. Advances in Anatomic Pathology, 25(5), 293–303.
Sanda, M. G., Cadeddu, J. A., Kirkby, E., Chen, R. C., Crispino, T., Fontanarosa, J., Freedland, S. J., Greene, K., Klotz, L. H., Makarov, D. V., Nelson, J. B., Rodrigues, G., Sandler, H. M., Taplin, M. E., & Treadwell, J. R. (2018a). Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: Risk stratification, shared decision making, and care options. The Journal of Urology, 199(3), 683–690.
Sanda, M. G., Cadeddu, J. A., Kirkby, E., Chen, R. C., Crispino, T., Fontanarosa, J., Freedland, S. J., Greene, K., Klotz, L. H., Makarov, D. V., Nelson, J. B., Rodrigues, G., Sandler, H. M., Taplin, M. E., & Treadwell, J. R. (2018b). Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: Recommended approaches and details of specific care options. The Journal of Urology, 199(4), 990–997.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Cimadamore, A. et al. (2020). Prostatic Acinar Adenocarcinoma. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5476-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_5476-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine